Prosecution Insights
Last updated: August 06, 2026

Jichi Medical University

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only1 (20%)
§102 only1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILSON, JERICA KATLYNN 1 61.5% +38.7%
BERA, HENA RAKESHKUMAR 1
SHEN, WU CHENG WINSTON 1 23.8% +25.6%
XU, QING 1 50.7% +54.7%
GRABER, JAMES J 1 45.9% +57.0%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18557131 METHOD FOR EXAMINING PROGRESSION OF CHRONIC KIDNEY DISEASE IN SUBJECT, AND KIT BERA, HENA RAKESHKUMAR
17914323 TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT SHEN, WU CHENG WINSTON
17042819 GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION GRABER, JAMES J

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17782531 PREPARATION OF ADIPOSE TISSUE-DERIVED CELL POPULATION XU, QING 21d
18721735 SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA WILSON, JERICA KATLYNN
17914323 TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT SHEN, WU CHENG WINSTON
17042819 GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION GRABER, JAMES J

Top Art Units

Art UnitApps
1798 1
1682 1
1656 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18721735 SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA WILSON, JERICA KATLYNN §102 Non-Final OA Pending Jun 19, 2024
18557131 METHOD FOR EXAMINING PROGRESSION OF CHRONIC KIDNEY DISEASE IN SUBJECT, AND KIT BERA, HENA RAKESHKUMAR 1798 §101§103§112 Non-Final OA Pending Oct 25, 2023
17914323 TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT SHEN, WU CHENG WINSTON 1682 §102§103§112 Non-Final OA Pending Sep 24, 2022
17782531 PREPARATION OF ADIPOSE TISSUE-DERIVED CELL POPULATION XU, QING 1656 §103 Final Rejection 21d Pending Jun 03, 2022
17042819 GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION GRABER, JAMES J 1631 §102§103 Non-Final OA Pending Sep 28, 2020

Managing Jichi Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month